The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6.
Open accessAbstract
Cell lines derived from Kaposi sarcoma lesions of patients with AIDS (AIDS-KS cells) produce several cytokines, including an endothelial cell growth factor, interleukin 1 beta, and basic fibroblast growth factor. Since exposure to human immunodeficiency virus increases interleukin 6 (IL-6) production in monocytes and endothelial cells produce IL-6, we examined IL-6 expression and response in AIDS-KS cell lines and IL-6 expression in AIDS Kaposi sarcoma tissue. The AIDS-KS cell lines (N521J and EKS3) secreted large amounts of immunoreactive and biologically active IL-6. We found both IL-6 and IL-6 receptor (IL-6-R) RNA by slot blot hybridization analysis of AIDS-KS cells. The IL-6-R was functional, as [3H]thymidine incorporation by AIDS-KS cells increased significantly after exposure to human recombinant IL-6 (hrIL-6) at greater than 10 units/ml. When AIDS-KS cells (EKS3) were exposed to IL-6 antisense oligonucleotide, cellular proliferation decreased by nearly two-thirds, with a corresponding decrease in the production of IL-6. The decrease from IL-6 antisense in AIDS-KS cell proliferation was reversed by the addition of hrIL-6. We confirmed that AIDS-KS cells produced IL-6 in vivo by preparing RNA and tissue sections from involved and uninvolved skin from a patient with AIDS Kaposi sarcoma. We detected immunoreactive IL-6 in the involved tumor areas and to a lesser extent in the surrounding normal epidermis. Slot blot hybridization showed a great excess of IL-6 and IL-6-R RNA in involved skin compared to uninvolved skin. These results show that both IL-6 and IL-6-R are produced by AIDS-KS cells and that IL-6 is required for optimal AIDS-KS cell proliferation, and they suggest that IL-6 is an autocrine growth factor for AIDS-KS cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
Self-citationGauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633
Self-citationCloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor
Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., & Kishimoto, T. (1988) · Science · doi:10.1126/science.3136546 · Cited by 1,060
Self-citationInfection with HIV is associated with elevated IL-6 levels and production.
Breen, E. C., Rezai, A. R., Nakajima, K., Beall, G. N., Mitsuyasu, R. T., Hirano, T., Kishimoto, T., & Martinez-Maza, O. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.2.480 · Cited by 578
Self-citationMolecular Regulation of B Lymphocyte Response
Kishimoto, T., & Hirano, T. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.002413 · Cited by 567
Self-citationStructure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene.
Yasukawa, K., Hirano, T., Watanabe, Y., Muratani, K., Matsuda, T., Nakai, S., & Kishimoto, T. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02598.x · Cited by 503
Self-citationAIDS-Kaposi's Sarcoma-Derived Cells Express Cytokines with Autocrine and Paracrine Growth Effects
Ensoli, B., Nakamura, S., Salahuddin, S. Z., Biberfeld, P., Larsson, L., Beaver, B., Wong-Staal, F., & Gallo, R. C. (1989) · Science · doi:10.1126/science.2643161 · Cited by 460
Angiogenic Properties of Kaposi's Sarcoma-Derived Cells After Long-Term Culture in Vitro
Salahuddin, S. Z., Nakamura, S., Biberfeld, P., Kaplan, M. H., Markham, P. D., Larsson, L., & Gallo, R. C. (1988) · Science · doi:10.1126/science.2459779 · Cited by 327
Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV.
Nakajima, K., Martínez-Maza, O., Hirano, T., Breen, E. C., Nishanian, P. G., Salazar-Gonzalez, J. F., Fahey, J. L., & Kishimoto, T. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.531 · Cited by 304
Self-citation
Cited by
Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M., Clauvel, J., Raphael, M., Degos, L., et al. (1995) · Blood · doi:10.1182/blood.v86.4.1276.bloodjournal8641276 · Cited by 2,157
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Self-citationRole of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
Cooperative Influence of Genetic Polymorphisms on Interleukin 6 Transcriptional Regulation
Terry, C. F., Loukaci, V., & Green, F. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000379200 · Cited by 800
Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells
Boshoff, C., Schulz, T. F., Kennedy, M. M., Graham, A. K., Fisher, C., Thomas, A., McGee, J. O., Weiss, R. A., & O'Leary, J. J. (1995) · Nature Medicine · doi:10.1038/nm1295-1274 · Cited by 681
IL-6 signal transduction and its physiological roles: the signal orchestration model
Kamimura, D., Ishihara, K., & Hirano, T. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0012-2 · Cited by 673
Self-citationInterleukin-6 and its receptor: a paradigm for cytokines
Kishimoto, T., Akira, S., & Taga, T. (1992) · Science · doi:10.1126/science.1411569 · Cited by 665
Self-citationRibatti, D., Presta, M., Vacca, A., Ria, R., Giuliani, R., Dell’Era, P., Nico, B., Roncali, L., & Dammacco, F. (1999) · Blood · doi:10.1182/blood.v93.8.2627 · Cited by 538
Angiogenic and HIV-Inhibitory Functions of KSHV-Encoded Chemokines
Boshoff, C., Endo, Y., Collins, P. D., Takeuchi, Y., Reeves, J. D., Schweickart, V. L., Siani, M. A., Sasaki, T., Williams, T. J., Gray, P. W., et al. (1997) · Science · doi:10.1126/science.278.5336.290 · Cited by 469
Boshoff, C., & Weiss, R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc797 · Cited by 443
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy
Nishimoto, N., Sasai, M., Shima, Y., Nakagawa, M., Matsumoto, T., Shirai, T., Kishimoto, T., & Yoshizaki, K. (2000) · Blood · doi:10.1182/blood.v95.1.56 · Cited by 441
Self-citationAoki, Y., Jaffe, E. S., Chang, Y., Jones, K., Teruya-Feldstein, J., Moore, P. S., & Tosato, G. (1999) · Blood · doi:10.1182/blood.v93.12.4034 · Cited by 427
Role of Monocytes in Atherogenesis
ØSTERUD, B., & BJØRKLID, E. (2003) · Physiological Reviews · doi:10.1152/physrev.00005.2003 · Cited by 412
IL-6 and NF-IL6 in acute-phase response and viral infection
Akira, S., & Kishimoto†, T. (1992) · Immunological Reviews · doi:10.1111/j.1600-065x.1992.tb01407.x · Cited by 411
Self-citationKinetics of Kaposi’s Sarcoma-Associated Herpesvirus Gene Expression
Sun, R., Lin, S.-F., Staskus, K., Gradoville, L., Grogan, E., Haase, A., & Miller, G. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2232-2242.1999 · Cited by 404
Neipel, F., Albrecht, J. C., & Fleckenstein, B. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4187-4192.1997 · Cited by 402
Kaposi's Sarcoma-Associated Herpesvirus
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60739-3 · Cited by 398
Significance of interleukin-6 (IL-6) in breast cancer (review)
Knüpfer, H., & Preiß, R. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9328-3 · Cited by 396
Nicholas, J., Ruvolo, V. R., Burns, W. H., Sandford, G., Wan, X., Ciufo, D., Hendrickson, S. B., Guo, H.-G., Hayward, G. S., & Reixz, M. S. (1997) · Nature Medicine · doi:10.1038/nm0397-287 · Cited by 389
Interleukin‐6: Structure‐function relationships
Simpson, R. J., Hammacher, A., Smith, D. K., Matthews, J. M., & Ward, L. D. (1997) · Protein Science · doi:10.1002/pro.5560060501 · Cited by 371
Macrophage-derived angiogenesis factors
Sunderkötter, C., Goebeler, M., Schulze-Osthoff, K., Bhardwaj, R., & Sorg, C. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90077-y · Cited by 332
Tappero, J. W., Conant, M. A., Wolfe, S. F., & Berger, T. G. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(93)70057-z · Cited by 309
Uldrick, T. S., Wang, V., O’Mahony, D., Aleman, K., Wyvill, K. M., Marshall, V., Steinberg, S. M., Pittaluga, S., Maric, I., Whitby, D., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/654798 · Cited by 304
KSHV INFECTION AND THE PATHOGENESIS OF KAPOSI'S SARCOMA
Ganem, D. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100133 · Cited by 298
Human herpesvirus 8 encodes a homolog of interleukin-6
Neipel, F., Albrecht, J. C., Ensser, A., Huang, Y. Q., Li, J. J., Friedman-Kien, A. E., & Fleckenstein, B. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.839-842.1997 · Cited by 292
Activity of Thalidomide in AIDS-Related Kaposi’s Sarcoma
Little, R. F., Wyvill, K. M., Pluda, J. M., Welles, L., Marshall, V., Figg, W. D., Newcomb, F. M., Tosato, G., Feigal, E., Steinberg, S. M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2593 · Cited by 290
How much is too much? Interleukin-6 and its signalling in atherosclerosis
Schuett, H., Luchtefeld, M., Grothusen, C., Grote, K., & Schieffer, B. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-05-0297 · Cited by 289
Buonaguro, L., Barillari, G., Chang, H. K., Bohan, C. A., Kao, V, Morgan, R., Gallo, R. C., & Ensoli, B. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7159-7167.1992 · Cited by 277
Ensoli, B., Sgadari, C., Barillari, G., Sirianni, M. C., Stürzl, M., & Monini, P. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00121-6 · Cited by 255
Chen, J. Y., Penco, S., Ostrowski, J., Balaguer, P., Pons, M., Starrett, J. E., Reczek, P., Chambon, P., & Gronemeyer, H. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07102.x · Cited by 255
Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides.
Monia, B. P., Johnston, J. F., Ecker, D. J., Zounes, M. A., Lima, W. F., & Freier, S. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88650-7 · Cited by 254
Hypoxia induces lytic replication of Kaposi sarcoma–associated herpesvirus
Davis, D. A., Rinderknecht, A. S., Zoeteweij, J. P., Aoki, Y., Read-Connole, E. L., Tosato, G., Blauvelt, A., & Yarchoan, R. (2001) · Blood · doi:10.1182/blood.v97.10.3244 · Cited by 253
Polizzotto, M. N., Uldrick, T. S., Wyvill, K. M., Aleman, K., Peer, C. J., Bevans, M., Sereti, I., Maldarelli, F., Whitby, D., Marshall, V., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.3812 · Cited by 138
Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma
Ma, Q., Cavallin, L. E., Yan, B., Zhu, S., Duran, E. M., Wang, H., Hale, L. P., Dong, C., Cesarman, E., Mesri, E. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812688106 · Cited by 105
Bian, Z., Fan, Q., Li, G., Xu, W., & Tang, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01731.x · Cited by 83
Metadata
- Authors
- Miles, S. A., Rezai, A. R., Salazar-González, J. F., Vander Meyden, M., Stevens, R. H., Logan, D. M., Mitsuyasu, R. T., Taga, T., Hirano, T., & Kishimoto, T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1990-06
- Volume
- 87
- Issue
- 11
- Pages
- 4068-4072
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2049070399
- Cited by
- 475
- References
- 17
- FWCI
- 12.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.